{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:22:35Z","timestamp":1789035755207,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006668","name":"Fund for Scientific and Technological Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009559","name":"National University of Quilmes","doi-asserted-by":"publisher","award":["2297\/22"],"award-info":[{"award-number":["2297\/22"]}],"id":[{"id":"10.13039\/501100009559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.heliyon.2025.e42238","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:14:14Z","timestamp":1737692054000},"page":"e42238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["CADD-based discovery of novel oligomeric modulators of PKM2 with antitumor activity in aggressive human glioblastoma models"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-5864","authenticated-orcid":false,"given":"Maia","family":"Cabrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Armando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Czarnowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Chinestrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Zinni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego L.","family":"Mengual G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Lorenzano","family":"Menna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2025.e42238_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1568026611313010006","article-title":"Impact of quaternary structure dynamics on allosteric drug discovery","volume":"13","author":"Jaffe","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e42238_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bmb.20211","article-title":"Expanding the concepts in protein structure-function relationships and enzyme kinetics: teaching using morpheeins","volume":"36","author":"Lawrence","year":"2008","journal-title":"Biochem. Mol. Biol. Educ."},{"issue":"9","key":"10.1016\/j.heliyon.2025.e42238_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tibs.2005.07.003","article-title":"Morpheeins--a new structural paradigm for allosteric regulation","volume":"30","author":"Jaffe","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.heliyon.2025.e42238_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/1477-3163.115423","article-title":"Cancer metabolism meets systems biology: pyruvate kinase isoform PKM2 is a metabolic master regulator","volume":"12","author":"Filipp","year":"2013","journal-title":"J. Carcinog."},{"issue":"7","key":"10.1016\/j.heliyon.2025.e42238_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.biocel.2010.02.005","article-title":"Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells","volume":"43","author":"Mazurek","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"27","key":"10.1016\/j.heliyon.2025.e42238_bib6","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1021\/bi0474923","article-title":"Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis","volume":"44","author":"Dombrauckas","year":"2005","journal-title":"Biochemistry"},{"issue":"97","key":"10.1016\/j.heliyon.2025.e42238_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000431","article-title":"Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth","volume":"2","author":"Hitosugi","year":"2009","journal-title":"Sci. Signal."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e42238_bib8","first-page":"99","article-title":"Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours","author":"Mazurek","year":"2007","journal-title":"Ernst Schering Found Symp Proc."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e42238_bib9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.semcancer.2005.04.009","article-title":"Pyruvate kinase type M2 and its role in tumor growth and spreading","volume":"15","author":"Mazurek","year":"2005","journal-title":"Semin. Cancer Biol."},{"issue":"7","key":"10.1016\/j.heliyon.2025.e42238_bib10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1039\/D1MD00045D","article-title":"Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents","volume":"12","author":"Rathod","year":"2021","journal-title":"RSC Med. Chem."},{"issue":"20","key":"10.1016\/j.heliyon.2025.e42238_bib11","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.2174\/0929867331666230714144851","article-title":"Recent advances on PKM2 inhibitors and activators in cancer applications","volume":"31","author":"Chen","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.heliyon.2025.e42238_bib12","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1021\/acs.jmedchem.8b00241","article-title":"Natural product micheliolide (MCL) irreversibly activates pyruvate kinase M2 and suppresses leukemia","volume":"61","author":"Li","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1017","key":"10.1016\/j.heliyon.2025.e42238_bib13","doi-asserted-by":"crossref","first-page":"e729","DOI":"10.1259\/bjr\/83796755","article-title":"A clinical review of treatment outcomes in glioblastoma multiforme--the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?","volume":"85","author":"Rock","year":"2012","journal-title":"Br. J. Radiol."},{"issue":"10","key":"10.1016\/j.heliyon.2025.e42238_bib14","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e42238_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jocn.2009.09.004","article-title":"Survival comparison between glioblastoma multiforme and other incurable cancers","volume":"17","author":"Tran","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.heliyon.2025.e42238_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102412","article-title":"Epidemiology of glioblastoma multiforme-literature review","volume":"14","author":"Grochans","year":"2022","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.heliyon.2025.e42238_bib17","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.heliyon.2025.e42238_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031171","article-title":"The role of PKM2 in metabolic reprogramming: insights into the regulatory roles of non-coding RNAs","volume":"22","author":"Puckett","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"42","key":"10.1016\/j.heliyon.2025.e42238_bib19","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.heliyon.2025.e42238_bib20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbrc.2020.05.139","article-title":"Identification of Gliotoxin isolated from marine fungus as a new pyruvate kinase M2 inhibitor","volume":"528","author":"Tang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.heliyon.2025.e42238_bib21","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2174\/187152011797378689","article-title":"Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation","volume":"11","author":"Candolfi","year":"2011","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"16","key":"10.1016\/j.heliyon.2025.e42238_bib22","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.7150\/jca.58494","article-title":"Shikonin inhibits tumor growth of ESCC by suppressing PKM2 mediated aerobic glycolysis and STAT3 phosphorylation","volume":"12","author":"Zhang","year":"2021","journal-title":"J. Cancer"},{"issue":"12","key":"10.1016\/j.heliyon.2025.e42238_bib23","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the worldwide protein Data Bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nat. Struct. Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e42238_bib24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"Pt 9","key":"10.1016\/j.heliyon.2025.e42238_bib25","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1107\/S2059798322007987","article-title":"CCP4 Cloud for structure determination and project management in macromolecular crystallography","volume":"78","author":"Krissinel","year":"2022","journal-title":"Acta Crystallogr D Struct Biol"},{"issue":"2","key":"10.1016\/j.heliyon.2025.e42238_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/neuonc\/nov125","article-title":"Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions","volume":"18","author":"Agnihotri","year":"2016","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42238_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"15","key":"10.1016\/j.heliyon.2025.e42238_bib28","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1093\/bioinformatics\/bti527","article-title":"A new progressive-iterative algorithm for multiple structure alignment","volume":"21","author":"Lupyan","year":"2005","journal-title":"Bioinformatics"},{"issue":"38","key":"10.1016\/j.heliyon.2025.e42238_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1107\/S0567739482001806","article-title":"Rapid comparison of protein structures","volume":"A","author":"McLachlan","year":"1982","journal-title":"Acta Cryst."},{"issue":"7424","key":"10.1016\/j.heliyon.2025.e42238_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature11540","article-title":"Serine is a natural ligand and allosteric activator of pyruvate kinase M2","volume":"491","author":"Chaneton","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2025.e42238_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1471-2105-10-168","article-title":"Fpocket: an open source platform for ligand pocket detection","volume":"10","author":"Le Guilloux","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.heliyon.2025.e42238_bib32","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8357.1","article-title":"Activity-relevant similarity values for fingerprints and implications for similarity searching","volume":"5","author":"Jasial","year":"2016","journal-title":"F1000Res"},{"issue":"9","key":"10.1016\/j.heliyon.2025.e42238_bib33","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.heliyon.2025.e42238_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42238_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"issue":"10","key":"10.1016\/j.heliyon.2025.e42238_bib36","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1021\/ct2002732","article-title":"Comparison of tetrahedral order, liquid state anomalies, and hydration behavior of mTIP3P and TIP4P water models","volume":"7","author":"Nayar","year":"2011","journal-title":"J Chem Theory Comput."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42238_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/ct700200b","article-title":"A parallel linear constraint solver for molecular simulation","volume":"4","author":"P-Lincs","year":"2008","journal-title":"J Chem Theory Comput."},{"issue":"12","key":"10.1016\/j.heliyon.2025.e42238_bib38","doi-asserted-by":"crossref","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u22c5log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.heliyon.2025.e42238_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/srep34984","article-title":"Structural insights into conformational stability of both wild-type and mutant EZH2 receptor","volume":"6","author":"Aier","year":"2016","journal-title":"Sci. Rep."},{"issue":"21","key":"10.1016\/j.heliyon.2025.e42238_bib40","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/bioinformatics\/btl461","article-title":"Bio3d: an R package for the comparative analysis of protein structures","volume":"22","author":"Grant","year":"2006","journal-title":"Bioinformatics"},{"issue":"10","key":"10.1016\/j.heliyon.2025.e42238_bib41","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/1062936X.2023.2261842","article-title":"Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches","volume":"34","author":"Baidya","year":"2023","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.heliyon.2025.e42238_bib42","first-page":"1","article-title":"A combined ligand-based and structure-based in silico molecular modeling approach to pinpoint the key structural attributes of hydroxamate derivatives as promising meprin \u03b2 inhibitors","author":"Jana","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.heliyon.2025.e42238_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2020.107322","article-title":"Geo-Measures: a PyMOL plugin for protein structure ensembles analysis","volume":"87","author":"Kagami","year":"2020","journal-title":"Comput. Biol. Chem."},{"issue":"8","key":"10.1016\/j.heliyon.2025.e42238_bib44","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1021\/acs.jcim.8b00261","article-title":"Steered molecular dynamics simulation in rational drug design","volume":"58","author":"Do","year":"2018","journal-title":"J. Chem. Inf. Model."},{"issue":"6","key":"10.1016\/j.heliyon.2025.e42238_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062731","article-title":"Steered molecular dynamics simulations study on FABP4 inhibitors","volume":"28","author":"Tomarchio","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.heliyon.2025.e42238_bib46","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2011.06.057","article-title":"Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach","volume":"410","author":"Mai","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42238_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1063\/1.447334","article-title":"A unified formulation of the constant temperature molecular dynamics methods","volume":"81","author":"Nos\u00e9","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e42238_bib48","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: equilibrium phase-space distributions","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys Rev A Gen Phys"},{"issue":"12","key":"10.1016\/j.heliyon.2025.e42238_bib49","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"5","key":"10.1016\/j.heliyon.2025.e42238_bib50","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/00268978300102851","article-title":"Constant pressure molecular dynamics for molecular systems","volume":"50","author":"Nos\u00e9","year":"1983","journal-title":"Mol. Phys."},{"key":"10.1016\/j.heliyon.2025.e42238_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105572","article-title":"Benchmarking the ability of novel compounds to inhibit SARS-CoV-2 main protease using steered molecular dynamics simulations","volume":"146","author":"Singh","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"50","key":"10.1016\/j.heliyon.2025.e42238_bib52","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1021\/acs.biochem.7b01013","article-title":"Structural investigation of a dimeric variant of pyruvate kinase muscle isoform 2","volume":"56","author":"Srivastava","year":"2017","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.heliyon.2025.e42238_bib53","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2020.03.182","article-title":"The cysteine residue at 424th of pyruvate kinase M2 is crucial for tetramerization and responsiveness to oxidative stress","volume":"526","author":"Masaki","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.heliyon.2025.e42238_bib54","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1021\/jm960352+","article-title":"Selecting optimally diverse compounds from structure databases: a validation study of two-dimensional and three-dimensional molecular descriptors","volume":"40","author":"Matter","year":"1997","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e42238_bib55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00018-007-6342-5","article-title":"Molecular targets of glioma invasion","volume":"64","author":"Nakada","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e42238_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/cns-2015-0006","article-title":"Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept","volume":"5","author":"Yuen","year":"2016","journal-title":"CNS Oncol"},{"issue":"2","key":"10.1016\/j.heliyon.2025.e42238_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057610","article-title":"Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma","volume":"8","author":"Mukherjee","year":"2013","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.heliyon.2025.e42238_bib58","doi-asserted-by":"crossref","first-page":"13006","DOI":"10.18632\/oncotarget.3514","article-title":"PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a\/c-Myc\/hnRNPA1 feedback loop","volume":"6","author":"Luan","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42238_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41598-018-36347-7","article-title":"Behaviors of glioblastoma cells in in vitro microenvironments","volume":"9","author":"Diao","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.heliyon.2025.e42238_bib60","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nchembio.1060","article-title":"Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis","volume":"8","author":"Anastasiou","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"5","key":"10.1016\/j.heliyon.2025.e42238_bib61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2174\/1570180813666160916153017","article-title":"Possible binding mode analysis of pyrazolo-triazole hybrids as potential anticancer agents through validated molecular docking and 3D-QSAR modeling approaches","volume":"14","author":"Amin","year":"2017","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.heliyon.2025.e42238_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107481","article-title":"Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: an in silico perspective for the identification of new potential HDAC3 inhibitors","volume":"166","author":"Lanka","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.heliyon.2025.e42238_bib63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-61779-588-6_10","article-title":"Methods of protein structure comparison","volume":"857","author":"Kufareva","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2025.e42238_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108051","article-title":"An assessment of crucial structural contributors of HDAC6 inhibitors through fragment-based non-linear pattern recognition and molecular dynamics simulation approaches","volume":"110","author":"Banerjee","year":"2024","journal-title":"Comput. Biol. Chem."},{"issue":"39","key":"10.1016\/j.heliyon.2025.e42238_bib65","doi-asserted-by":"crossref","first-page":"15290","DOI":"10.1074\/jbc.RA118.004512","article-title":"CARM1 suppresses de novo serine synthesis by promoting PKM2 activity","volume":"293","author":"Abeywardana","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.heliyon.2025.e42238_bib66","doi-asserted-by":"crossref","first-page":"694","DOI":"10.21873\/invivo.12755","article-title":"PKM2 is overexpressed in glioma tissues, and its inhibition highly increases late apoptosis in U87MG cells with low-density specificity","volume":"36","author":"Park","year":"2022","journal-title":"Vivo"},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42238_bib67","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/13880209.2020.1818793","article-title":"Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review","volume":"58","author":"Zhang","year":"2020","journal-title":"Pharm. Biol."},{"issue":"24","key":"10.1016\/j.heliyon.2025.e42238_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413510","article-title":"The toxic mechanism of gliotoxins and biosynthetic strategies for toxicity prevention","volume":"22","author":"Ye","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2025.e42238_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fonc.2020.00159","article-title":"Pyruvate kinase M2 and cancer: the role of PKM2 in promoting tumorigenesis","volume":"10","author":"Zahra","year":"2020","journal-title":"Front. Oncol."},{"issue":"45","key":"10.1016\/j.heliyon.2025.e42238_bib70","doi-asserted-by":"crossref","first-page":"19135","DOI":"10.1073\/pnas.1014047107","article-title":"Uncoupling the Warburg effect from cancer","volume":"107","author":"Najafov","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.heliyon.2025.e42238_bib71","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s13238-020-00725-7","article-title":"Regulation of aerobic glycolysis to decelerate tumor proliferation by small molecule inhibitors targeting glucose transporters","volume":"11","author":"Gao","year":"2020","journal-title":"Protein Cell"},{"issue":"9","key":"10.1016\/j.heliyon.2025.e42238_bib72","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1242\/jcs.114.9.1655","article-title":"Pyruvate kinase M2 at a glance","volume":"128","author":"Yang","year":"2015","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2025.e42238_bib73","first-page":"35","article-title":"The interplay between MYC and HIF in the Warburg effect","author":"Dang","year":"2007","journal-title":"Ernst Schering Found Symp Proc."},{"issue":"1","key":"10.1016\/j.heliyon.2025.e42238_bib74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nbd.2011.06.007","article-title":"Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme","volume":"44","author":"Wolf","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2025.e42238_bib75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/cr.2016.159","article-title":"Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2","volume":"27","author":"Liang","year":"2017","journal-title":"Cell Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025006188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844025006188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:39:02Z","timestamp":1775738342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844025006188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2405844025006188"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42238","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CADD-based discovery of novel oligomeric modulators of PKM2 with antitumor activity in aggressive human glioblastoma models","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2025.e42238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e42238"}}